Major pharmaceutical players Eli Lilly (NYSE:LLY), AbbVie (NYSE:ABBV) and Pfizer (NYSE:PFE) reported mixed Q3 results, with each company facing distinct...
Read moreIron ore prices have displayed volatility in the past few years as the world has dealt with the economic uncertainty...
Read moreReferring to the World Gold Council’s latest report, he highlighted the return of western exchange-traded fund investors. With interest rates...
Read moreA contraction continued in the cobalt market during the year’s third quarter, with metal values falling from US$27,151.50 per metric...
Read morePiche Resources Limited (ASX: PR2) (“Piche” or the “Company”) is pleased to announce drilling results from a further eight holes...
Read moreLivium Ltd (ASX: LIT) (‘Livium’ or the ‘Company’) is pleased to announce that its wholly owned subsidiary Envirostream Australia Pty...
Read moreAllup Silica Limited (ASX: APS) (“Allup” or “Company”) is pleased to announce recent exploration results from its Pink Bark Project...
Read morePatronus Resources Limited (ASX: PTN; “Patronus” or “the Company”) is pleased to advise that the Northern Territory Government has approved...
Read moreBlackstone Minerals Limited (“Blackstone” or the “Company”) is pleased to announce that it is undertaking a partially underwritten accelerated non-renounceable...
Read moreAdisyn Ltd (ASX: AI1) (“Adisyn” or the “Company”) is pleased to announce, further to its previous announcement on 23 October...
Read moreDisclaimer: economicfinesse.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Copyright © 2024 Economic Finesse. All Rights Reserved.